Cargando…
MiR-195 and Its Target SEMA6D Regulate Chemoresponse in Breast Cancer
SIMPLE SUMMARY: The resistance of cancer cells to cytotoxic chemotherapy limits cure rates in breast cancer, and a better understanding of resistance mechanisms will aid design of strategies to improve treatments. We have identified molecules that cause chemoresistance through comparison of matched...
Autores principales: | Baxter, Diana E., Allinson, Lisa M., Al Amri, Waleed S., Poulter, James A., Pramanik, Arindam, Thorne, James L., Verghese, Eldo T., Hughes, Thomas A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656586/ https://www.ncbi.nlm.nih.gov/pubmed/34885090 http://dx.doi.org/10.3390/cancers13235979 |
Ejemplares similares
-
Identification of candidate mediators of chemoresponse in breast cancer through therapy-driven selection of somatic variants
por: Al Amri, Waleed S., et al.
Publicado: (2020) -
miRNA Profiles as a Predictor of Chemoresponsiveness in Wilms’ Tumor Blastema
por: Watson, Jenny A., et al.
Publicado: (2013) -
In vitro chemoresponse in metachronous pairs of gyneclologic cancers
por: Dalton, Heather J, et al.
Publicado: (2014) -
Transcriptome profiles of stem-like cells from primary breast cancers allow identification of ITGA7 as a predictive marker of chemotherapy response
por: Gwili, Noha, et al.
Publicado: (2021) -
Evaluation of chemoresponse assays as predictive markers
por: Korn, E L, et al.
Publicado: (2015)